Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | 22694318 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 100000 | nM | 17896816 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | 7525959 | |
NPT466 | Cell Line | U-937 | Homo sapiens | IC50 | = | 191900 | nM | 23567957 |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | Open TG-GATES in vivo data: Hematology | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 100000 | nM | 15646539 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 100000 | nM | 25630222 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 100000 | nM | 17567121 | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 100000 | nM | 21920638 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 100000 | nM | 24087924 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 100000 | nM | 24183589 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 100000 | nM | 25856683 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | 22206869 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 100000 | nM | 17850214 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 100000 | nM | 12027740 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | 17918910 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | 17722904 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vivo data: Hematology | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | 23369536 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 100000 | nM | 19128055 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | 21982796 | |
NPT76 | Cell Line | C6 | Rattus norvegicus | IC50 | = | 76400 | nM | 10.6019/CHEMBL1201861 |
NPT2 | Others | Unspecified | IC50 | = | 75600 | nM | 10.6019/CHEMBL1201861 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 100000 | nM | 18077363 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | 20022253 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | 15730242 | |
NPT466 | Cell Line | U-937 | Homo sapiens | CC50 | = | 420000 | nM | 19581457 |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 100000 | nM | 19581457 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | 20584605 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | 25585025 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | 11908979 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | 26358281 | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 100000 | nM | 18183025 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | 23398362 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 71944.9 | nM | 23398362 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 100000 | nM | 23398362 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | 22123322 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | 11325232 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 100000 | nM | 23350733 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 100000 | nM | 23149227 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 100000 | nM | 26005918 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 100000 | nM | 7143376 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | 17035027 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | 18809939 | |
NPT466 | Cell Line | U-937 | Homo sapiens | Activity | = | 38 | % | 18362195 |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | 18519713 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | 21515059 | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 100000 | nM | DrugMatrix in vitro pharmacology data | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 100000 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | 24126094 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | 10.1016/j.cropro.2012.12.021 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 100000 | nM | 19627125 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | 8229009 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | 17887720 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 100000 | nM | 17958396 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC476450 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9424 | High Similarity | NPC300611 |
0.9371 | High Similarity | NPC96294 |
0.9348 | High Similarity | NPC20796 |
0.9343 | High Similarity | NPC240915 |
0.9241 | High Similarity | NPC114740 |
0.9178 | High Similarity | NPC213197 |
0.9172 | High Similarity | NPC212670 |
0.9172 | High Similarity | NPC206264 |
0.9172 | High Similarity | NPC313334 |
0.9155 | High Similarity | NPC138212 |
0.9143 | High Similarity | NPC164148 |
0.9143 | High Similarity | NPC43500 |
0.913 | High Similarity | NPC7163 |
0.9116 | High Similarity | NPC470264 |
0.9097 | High Similarity | NPC205361 |
0.9065 | High Similarity | NPC73071 |
0.9034 | High Similarity | NPC52740 |
0.9034 | High Similarity | NPC41844 |
0.9014 | High Similarity | NPC472520 |
0.9014 | High Similarity | NPC279851 |
0.9007 | High Similarity | NPC13067 |
0.9 | High Similarity | NPC126682 |
0.9 | High Similarity | NPC82271 |
0.8986 | High Similarity | NPC137669 |
0.8973 | High Similarity | NPC93924 |
0.8936 | High Similarity | NPC76336 |
0.8936 | High Similarity | NPC148835 |
0.8936 | High Similarity | NPC139548 |
0.8936 | High Similarity | NPC95162 |
0.8936 | High Similarity | NPC52086 |
0.8936 | High Similarity | NPC20511 |
0.8921 | High Similarity | NPC241341 |
0.8921 | High Similarity | NPC36437 |
0.8921 | High Similarity | NPC233018 |
0.8905 | High Similarity | NPC27239 |
0.8905 | High Similarity | NPC123127 |
0.8904 | High Similarity | NPC15577 |
0.8881 | High Similarity | NPC476442 |
0.8881 | High Similarity | NPC215512 |
0.8874 | High Similarity | NPC284810 |
0.8859 | High Similarity | NPC476352 |
0.8859 | High Similarity | NPC215060 |
0.8857 | High Similarity | NPC309953 |
0.8841 | High Similarity | NPC240722 |
0.8841 | High Similarity | NPC244799 |
0.8828 | High Similarity | NPC471763 |
0.8786 | High Similarity | NPC26673 |
0.8776 | High Similarity | NPC296377 |
0.8732 | High Similarity | NPC103409 |
0.8725 | High Similarity | NPC21184 |
0.8725 | High Similarity | NPC294522 |
0.8725 | High Similarity | NPC120426 |
0.8725 | High Similarity | NPC205727 |
0.8723 | High Similarity | NPC92830 |
0.8716 | High Similarity | NPC478237 |
0.8716 | High Similarity | NPC169510 |
0.8714 | High Similarity | NPC319969 |
0.8705 | High Similarity | NPC19242 |
0.8699 | High Similarity | NPC297342 |
0.8681 | High Similarity | NPC210478 |
0.8675 | High Similarity | NPC150442 |
0.8662 | High Similarity | NPC472521 |
0.8662 | High Similarity | NPC33986 |
0.8662 | High Similarity | NPC472525 |
0.8658 | High Similarity | NPC176903 |
0.8658 | High Similarity | NPC30688 |
0.8652 | High Similarity | NPC469449 |
0.8649 | High Similarity | NPC476347 |
0.8643 | High Similarity | NPC29734 |
0.8639 | High Similarity | NPC85624 |
0.863 | High Similarity | NPC230157 |
0.863 | High Similarity | NPC236419 |
0.8611 | High Similarity | NPC270256 |
0.8609 | High Similarity | NPC169404 |
0.8609 | High Similarity | NPC176186 |
0.8609 | High Similarity | NPC53587 |
0.8601 | High Similarity | NPC167517 |
0.8601 | High Similarity | NPC25695 |
0.8601 | High Similarity | NPC172818 |
0.8601 | High Similarity | NPC37468 |
0.8601 | High Similarity | NPC104167 |
0.8592 | High Similarity | NPC62366 |
0.8592 | High Similarity | NPC98179 |
0.8592 | High Similarity | NPC180716 |
0.8592 | High Similarity | NPC213173 |
0.8592 | High Similarity | NPC253574 |
0.8592 | High Similarity | NPC224475 |
0.8591 | High Similarity | NPC476348 |
0.8591 | High Similarity | NPC187398 |
0.8582 | High Similarity | NPC137949 |
0.8581 | High Similarity | NPC199928 |
0.8571 | High Similarity | NPC113098 |
0.8571 | High Similarity | NPC474491 |
0.8542 | High Similarity | NPC232246 |
0.8542 | High Similarity | NPC155963 |
0.8542 | High Similarity | NPC153818 |
0.8533 | High Similarity | NPC106138 |
0.8523 | High Similarity | NPC87950 |
0.8523 | High Similarity | NPC471764 |
0.8521 | High Similarity | NPC277021 |
0.8511 | High Similarity | NPC73738 |
0.8511 | High Similarity | NPC272650 |
0.8511 | High Similarity | NPC267336 |
0.8506 | High Similarity | NPC473323 |
0.8503 | High Similarity | NPC91492 |
0.8503 | High Similarity | NPC256555 |
0.8503 | High Similarity | NPC7439 |
0.8503 | High Similarity | NPC110067 |
0.8503 | High Similarity | NPC34245 |
0.8487 | Intermediate Similarity | NPC302610 |
0.8487 | Intermediate Similarity | NPC120774 |
0.8487 | Intermediate Similarity | NPC264875 |
0.8487 | Intermediate Similarity | NPC163598 |
0.8483 | Intermediate Similarity | NPC226005 |
0.8483 | Intermediate Similarity | NPC100389 |
0.8483 | Intermediate Similarity | NPC151946 |
0.8478 | Intermediate Similarity | NPC27352 |
0.8472 | Intermediate Similarity | NPC186418 |
0.8472 | Intermediate Similarity | NPC188380 |
0.8472 | Intermediate Similarity | NPC38099 |
0.8472 | Intermediate Similarity | NPC26954 |
0.8472 | Intermediate Similarity | NPC224543 |
0.8472 | Intermediate Similarity | NPC286843 |
0.8472 | Intermediate Similarity | NPC78746 |
0.8462 | Intermediate Similarity | NPC204353 |
0.8462 | Intermediate Similarity | NPC147030 |
0.8462 | Intermediate Similarity | NPC50896 |
0.8462 | Intermediate Similarity | NPC326600 |
0.8457 | Intermediate Similarity | NPC169645 |
0.8457 | Intermediate Similarity | NPC84482 |
0.8456 | Intermediate Similarity | NPC162193 |
0.8451 | Intermediate Similarity | NPC5423 |
0.8451 | Intermediate Similarity | NPC299144 |
0.8451 | Intermediate Similarity | NPC162093 |
0.8446 | Intermediate Similarity | NPC292443 |
0.8446 | Intermediate Similarity | NPC232228 |
0.8435 | Intermediate Similarity | NPC145319 |
0.8435 | Intermediate Similarity | NPC469564 |
0.8431 | Intermediate Similarity | NPC16791 |
0.8431 | Intermediate Similarity | NPC217708 |
0.8431 | Intermediate Similarity | NPC126405 |
0.8431 | Intermediate Similarity | NPC297271 |
0.8431 | Intermediate Similarity | NPC308739 |
0.8431 | Intermediate Similarity | NPC53669 |
0.8431 | Intermediate Similarity | NPC77237 |
0.8429 | Intermediate Similarity | NPC474616 |
0.8425 | Intermediate Similarity | NPC312881 |
0.8421 | Intermediate Similarity | NPC224472 |
0.8414 | Intermediate Similarity | NPC184861 |
0.8414 | Intermediate Similarity | NPC294456 |
0.8414 | Intermediate Similarity | NPC225106 |
0.8414 | Intermediate Similarity | NPC212124 |
0.8414 | Intermediate Similarity | NPC281014 |
0.8411 | Intermediate Similarity | NPC283839 |
0.8411 | Intermediate Similarity | NPC90896 |
0.8403 | Intermediate Similarity | NPC55040 |
0.8403 | Intermediate Similarity | NPC234865 |
0.8403 | Intermediate Similarity | NPC185778 |
0.84 | Intermediate Similarity | NPC178129 |
0.84 | Intermediate Similarity | NPC231149 |
0.8397 | Intermediate Similarity | NPC241600 |
0.8397 | Intermediate Similarity | NPC173726 |
0.8392 | Intermediate Similarity | NPC49074 |
0.8392 | Intermediate Similarity | NPC215833 |
0.8392 | Intermediate Similarity | NPC58585 |
0.8392 | Intermediate Similarity | NPC69513 |
0.8392 | Intermediate Similarity | NPC25821 |
0.8392 | Intermediate Similarity | NPC472522 |
0.8378 | Intermediate Similarity | NPC252169 |
0.8378 | Intermediate Similarity | NPC81638 |
0.8378 | Intermediate Similarity | NPC478239 |
0.8377 | Intermediate Similarity | NPC198461 |
0.8369 | Intermediate Similarity | NPC48315 |
0.8367 | Intermediate Similarity | NPC152771 |
0.8367 | Intermediate Similarity | NPC287286 |
0.8367 | Intermediate Similarity | NPC195357 |
0.8357 | Intermediate Similarity | NPC224774 |
0.8357 | Intermediate Similarity | NPC121740 |
0.8357 | Intermediate Similarity | NPC258567 |
0.8356 | Intermediate Similarity | NPC279573 |
0.8345 | Intermediate Similarity | NPC157554 |
0.8345 | Intermediate Similarity | NPC471719 |
0.8344 | Intermediate Similarity | NPC139839 |
0.8333 | Intermediate Similarity | NPC13745 |
0.8333 | Intermediate Similarity | NPC55149 |
0.8333 | Intermediate Similarity | NPC48863 |
0.8333 | Intermediate Similarity | NPC111635 |
0.8333 | Intermediate Similarity | NPC307412 |
0.8333 | Intermediate Similarity | NPC251981 |
0.8333 | Intermediate Similarity | NPC474600 |
0.8322 | Intermediate Similarity | NPC245120 |
0.8322 | Intermediate Similarity | NPC14248 |
0.8322 | Intermediate Similarity | NPC110063 |
0.8322 | Intermediate Similarity | NPC123954 |
0.8312 | Intermediate Similarity | NPC24562 |
0.8311 | Intermediate Similarity | NPC157816 |
0.8311 | Intermediate Similarity | NPC287124 |
0.8311 | Intermediate Similarity | NPC475084 |
0.8311 | Intermediate Similarity | NPC174522 |
0.831 | Intermediate Similarity | NPC476399 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC476450 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9172 | High Similarity | NPD1653 | Approved |
0.8 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7927 | Intermediate Similarity | NPD3818 | Discontinued |
0.784 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7823 | Intermediate Similarity | NPD1613 | Approved |
0.7823 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7801 | Intermediate Similarity | NPD422 | Phase 1 |
0.7801 | Intermediate Similarity | NPD1091 | Approved |
0.7798 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.774 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7736 | Intermediate Similarity | NPD37 | Approved |
0.7702 | Intermediate Similarity | NPD4966 | Approved |
0.7702 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7702 | Intermediate Similarity | NPD4965 | Approved |
0.7665 | Intermediate Similarity | NPD7054 | Approved |
0.7665 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7651 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7651 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.764 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7636 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7632 | Intermediate Similarity | NPD7266 | Discontinued |
0.7619 | Intermediate Similarity | NPD7472 | Approved |
0.7607 | Intermediate Similarity | NPD6234 | Discontinued |
0.7589 | Intermediate Similarity | NPD1357 | Approved |
0.7578 | Intermediate Similarity | NPD2801 | Approved |
0.7552 | Intermediate Similarity | NPD3705 | Approved |
0.7551 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7515 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7485 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7485 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD7549 | Discontinued |
0.7485 | Intermediate Similarity | NPD3882 | Suspended |
0.7483 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7471 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7452 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7439 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7427 | Intermediate Similarity | NPD7251 | Discontinued |
0.7427 | Intermediate Similarity | NPD6559 | Discontinued |
0.7423 | Intermediate Similarity | NPD5402 | Approved |
0.7417 | Intermediate Similarity | NPD447 | Suspended |
0.7407 | Intermediate Similarity | NPD1934 | Approved |
0.7396 | Intermediate Similarity | NPD7228 | Approved |
0.7394 | Intermediate Similarity | NPD919 | Approved |
0.7361 | Intermediate Similarity | NPD3496 | Discontinued |
0.7358 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7349 | Intermediate Similarity | NPD5494 | Approved |
0.7333 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7308 | Intermediate Similarity | NPD6674 | Discontinued |
0.7303 | Intermediate Similarity | NPD230 | Phase 1 |
0.7256 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7256 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7233 | Intermediate Similarity | NPD6799 | Approved |
0.7233 | Intermediate Similarity | NPD1511 | Approved |
0.7225 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7225 | Intermediate Similarity | NPD7240 | Approved |
0.7215 | Intermediate Similarity | NPD6190 | Approved |
0.7202 | Intermediate Similarity | NPD1247 | Approved |
0.72 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7195 | Intermediate Similarity | NPD6801 | Discontinued |
0.7176 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7176 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7175 | Intermediate Similarity | NPD6841 | Approved |
0.7175 | Intermediate Similarity | NPD6843 | Phase 3 |
0.7175 | Intermediate Similarity | NPD6842 | Approved |
0.7159 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7152 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7314 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD1512 | Approved |
0.7134 | Intermediate Similarity | NPD2424 | Discontinued |
0.7101 | Intermediate Similarity | NPD8127 | Discontinued |
0.7101 | Intermediate Similarity | NPD290 | Approved |
0.7101 | Intermediate Similarity | NPD1358 | Approved |
0.7099 | Intermediate Similarity | NPD5403 | Approved |
0.7099 | Intermediate Similarity | NPD920 | Approved |
0.7095 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7095 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7095 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD3751 | Discontinued |
0.7081 | Intermediate Similarity | NPD5401 | Approved |
0.7078 | Intermediate Similarity | NPD1933 | Approved |
0.707 | Intermediate Similarity | NPD1375 | Discontinued |
0.707 | Intermediate Similarity | NPD5762 | Approved |
0.707 | Intermediate Similarity | NPD5763 | Approved |
0.7069 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD5058 | Phase 3 |
0.7059 | Intermediate Similarity | NPD3787 | Discontinued |
0.7059 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7055 | Intermediate Similarity | NPD3686 | Approved |
0.7055 | Intermediate Similarity | NPD1778 | Approved |
0.7055 | Intermediate Similarity | NPD3687 | Approved |
0.7052 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7044 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7027 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7025 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7024 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7024 | Intermediate Similarity | NPD7075 | Discontinued |
0.702 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7019 | Intermediate Similarity | NPD4357 | Discontinued |
0.7013 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7006 | Intermediate Similarity | NPD1551 | Phase 2 |
0.6993 | Remote Similarity | NPD1296 | Phase 2 |
0.6993 | Remote Similarity | NPD1699 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD4908 | Phase 1 |
0.697 | Remote Similarity | NPD6599 | Discontinued |
0.697 | Remote Similarity | NPD4380 | Phase 2 |
0.6968 | Remote Similarity | NPD6355 | Discontinued |
0.6966 | Remote Similarity | NPD5536 | Phase 2 |
0.6959 | Remote Similarity | NPD1610 | Phase 2 |
0.6957 | Remote Similarity | NPD9697 | Approved |
0.6946 | Remote Similarity | NPD7819 | Suspended |
0.6946 | Remote Similarity | NPD8455 | Phase 2 |
0.6943 | Remote Similarity | NPD7033 | Discontinued |
0.6937 | Remote Similarity | NPD3750 | Approved |
0.6937 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6937 | Remote Similarity | NPD4110 | Phase 3 |
0.6933 | Remote Similarity | NPD3225 | Approved |
0.6923 | Remote Similarity | NPD6653 | Approved |
0.6905 | Remote Similarity | NPD5353 | Approved |
0.6901 | Remote Similarity | NPD228 | Approved |
0.6899 | Remote Similarity | NPD2796 | Approved |
0.6899 | Remote Similarity | NPD2935 | Discontinued |
0.6883 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6883 | Remote Similarity | NPD6798 | Discontinued |
0.6883 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD7097 | Phase 1 |
0.6875 | Remote Similarity | NPD1243 | Approved |
0.6871 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6867 | Remote Similarity | NPD4749 | Approved |
0.686 | Remote Similarity | NPD6232 | Discontinued |
0.6859 | Remote Similarity | NPD4340 | Discontinued |
0.6852 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6851 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.6835 | Remote Similarity | NPD3748 | Approved |
0.6832 | Remote Similarity | NPD7982 | Clinical (unspecified phase) |
0.6828 | Remote Similarity | NPD6671 | Approved |
0.6818 | Remote Similarity | NPD7095 | Approved |
0.6813 | Remote Similarity | NPD1549 | Phase 2 |
0.681 | Remote Similarity | NPD5297 | Approved |
0.6809 | Remote Similarity | NPD2684 | Approved |
0.6805 | Remote Similarity | NPD6374 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD9717 | Approved |
0.6795 | Remote Similarity | NPD4140 | Approved |
0.6786 | Remote Similarity | NPD3134 | Approved |
0.6783 | Remote Similarity | NPD969 | Suspended |
0.6776 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD2797 | Approved |
0.6774 | Remote Similarity | NPD7985 | Registered |
0.677 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD4236 | Phase 3 |
0.677 | Remote Similarity | NPD4237 | Approved |
0.6768 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD2532 | Approved |
0.6768 | Remote Similarity | NPD2533 | Approved |
0.6768 | Remote Similarity | NPD2534 | Approved |
0.6766 | Remote Similarity | NPD4678 | Approved |
0.6766 | Remote Similarity | NPD4675 | Approved |
0.6757 | Remote Similarity | NPD5691 | Approved |
0.6752 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD6002 | Phase 3 |
0.675 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD6005 | Phase 3 |
0.675 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD6004 | Phase 3 |
0.675 | Remote Similarity | NPD3540 | Phase 1 |
0.675 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6746 | Remote Similarity | NPD2977 | Approved |
0.6746 | Remote Similarity | NPD2978 | Approved |
0.6744 | Remote Similarity | NPD5677 | Discontinued |
0.6743 | Remote Similarity | NPD7473 | Discontinued |
0.6739 | Remote Similarity | NPD291 | Approved |
0.6736 | Remote Similarity | NPD7843 | Approved |
0.6733 | Remote Similarity | NPD1611 | Approved |
0.6731 | Remote Similarity | NPD1726 | Clinical (unspecified phase) |
0.673 | Remote Similarity | NPD1510 | Phase 2 |
0.6726 | Remote Similarity | NPD7411 | Suspended |
0.6724 | Remote Similarity | NPD3926 | Phase 2 |
0.6722 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6712 | Remote Similarity | NPD7157 | Approved |
0.6711 | Remote Similarity | NPD8651 | Approved |
0.6711 | Remote Similarity | NPD4626 | Approved |
0.6711 | Remote Similarity | NPD6696 | Suspended |
0.671 | Remote Similarity | NPD4625 | Phase 3 |
0.6709 | Remote Similarity | NPD2492 | Phase 1 |
0.6707 | Remote Similarity | NPD6055 | Clinical (unspecified phase) |
0.6707 | Remote Similarity | NPD1774 | Approved |
0.669 | Remote Similarity | NPD5283 | Phase 1 |
0.6688 | Remote Similarity | NPD9494 | Approved |
0.6687 | Remote Similarity | NPD3539 | Phase 1 |
0.6687 | Remote Similarity | NPD2219 | Phase 1 |
0.6687 | Remote Similarity | NPD2677 | Approved |
0.6687 | Remote Similarity | NPD6032 | Approved |
0.6667 | Remote Similarity | NPD7028 | Phase 2 |
0.6667 | Remote Similarity | NPD1203 | Approved |
PubChem CID   | 179597 |
ChEMBL   | CHEMBL611815 |
ZINC   |
Molecular Weight:   | 308.09 |
ALogP:   | -0.5521 |
MLogP:   | 2.34 |
XLogP:   | 0.586 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 94.45 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |